Revolutionary Gene Therapy for Hemophilia B

This chapter explores a groundbreaking clinical trial showcasing how gene therapy can effectively treat hemophilia B, leading to significant improvements in patients' lives. The discussion highlights the potential for long-term benefits, as some participants produced their own Factor IX, drastically reducing the need for infusions for up to 15 months.